Ovarian Stimulation Clinical Trial
Official title:
Mechanical Stimulation of the Ovary for Infertility Treatment in Patients With Very Low Ovarian Reserve
Examine the possibility that mechanical stimulation and ovarian fragmentation in women with premature ovarian failure or low ovarian reserve intended for egg donation may cause early follicular recruitment and increase chances of achieving pregnancy through IVF.
Status | Not yet recruiting |
Enrollment | 10 |
Est. completion date | September 1, 2019 |
Est. primary completion date | September 1, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 21 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Healthy women, aged 21-40. with premature ovarian failure. - Healthy women, with poor ovarian reserve, aged 38-45, undergoing IVF Low ovarian response: recruitment of up to three eggs in previous treatments. - After the failure of at least 4 cycles. - Two functioning ovaries, follicular and hormonal response of both ovaries in prior therapies. - Women candidates for egg donation, and seeking further treatment before switching to egg donation. Exclusion Criteria: - Women with kidney disease. - Women with infertility factors other than ovarian failure, such as endometriosis, PCOS, male factor. - Women with one non-functioning ovary, or that was removed. - Women with an intrauterine or pelvic pathology. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Sheba Medical Center |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Menstrual cycle surveillance | Duration of the menstrual period (days) | 2 years | |
Primary | AMH | Ovarian reserve measurements. AMH levels ng/ml | 2 years | |
Primary | Estradiol | Estradiol levels at day of HCG in Pmol/L | 2 years | |
Primary | Antral follicular count | measurement of. any antral follicles at day 3-5 with ultrasound | 2 years | |
Primary | IVF outcomes | Number of oocytes at OPU | 2 years | |
Primary | FSH levels | FSH levels at. day 2-3 of menstruation IU/L | 2 years | |
Primary | IVF outcomes fertilization rates | fertilization rate. - number of fertilized oocytes relatively to total number of oocytes | 2 years | |
Primary | IVF outcomes | pregnancy rates | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01121991 -
A Prospective Study to Evaluate the Addition of Subcutaneous Recombinant Human-Luteinizing Hormone With Recombinant Human-Follicle Stimulating Hormone on Follicular Development in Women Undergoing Ovarian Stimulation for Assisted Reproductive Technologies
|
Phase 3 | |
Not yet recruiting |
NCT04539067 -
Effect of Controlled Ovarian Stimulation in Quality of Oocyte and Embryo
|
Phase 2 | |
Recruiting |
NCT02715336 -
Efficacy and Safety of Medication Used to Stimulate Ovulation
|
Phase 4 | |
Completed |
NCT03939403 -
Conventional Ovarian Stimulation vs. Single Injection Stimulation of Corifollitropin Alfa in Oocyte Donor
|
Phase 4 | |
Recruiting |
NCT06142708 -
The Effect of Dual Trigger (GnRH Agonist + hCG) for Final Maturation in Oocyte Donors With History of a Previous Cycle With Suboptimal Response to GnRH Agonist Only Trigger
|
N/A | |
Recruiting |
NCT05166668 -
Letrozole /GnRH Antagonist Protocol in Women Over 40 Years Undergoing ICSI Cycle
|
N/A | |
Completed |
NCT04549649 -
The Effect of Dual Trigger for Final Oocyte Maturation on IVF/ICSI Outcomes in Patients With Suboptimal Ovarian Response
|
N/A | |
Terminated |
NCT01816789 -
Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles
|
Phase 4 | |
Completed |
NCT00823004 -
Antagonist/Letrozole in Poor Responders
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT06175832 -
PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study
|
Phase 4 | |
Completed |
NCT01145144 -
Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment
|
N/A | |
Completed |
NCT00830492 -
Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist
|
Phase 4 | |
Completed |
NCT01037699 -
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
|
Phase 3 | |
Completed |
NCT00829075 -
Impact of Three Different Gonadotrophin Regimes on Egg Donation Program
|
Phase 4 | |
Completed |
NCT01112358 -
Lutropin Alfa in Women at Risk of Poor Response
|
Phase 2 | |
Recruiting |
NCT03400722 -
Double Ovarian Stimulation as Accumulation Strategy for Older Infertile Patients With Suboptimal Ovarian Response
|
Phase 4 | |
Completed |
NCT00669786 -
Human Menopausal Gonadotropin (HMG) vs Recombinant Follicle Stimulating Hormone (rFSH) in Gonadotropin Releasing Hormone (GnRH) Antagonist Cycles
|
Phase 3 |